SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001493152-18-016669
Filing Date
2018-11-23
Accepted
2018-11-23 06:15:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc-13d.htm SC 13D 56407
  Complete submission text file 0001493152-18-016669.txt   58169
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filed by) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12264 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SAN DIEGO CA 92130 858-704-4040
Eton Pharmaceuticals, Inc. (Subject) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90726 | Film No.: 181199165
SIC: 2834 Pharmaceutical Preparations